A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C†
Version of Record online: 26 APR 2007
Copyright © 2007 American Association for the Study of Liver Diseases
Volume 46, Issue 2, pages 297–306, August 2007
How to Cite
Huang, H., Shiffman, M. L., Friedman, S., Venkatesh, R., Bzowej, N., Abar, O. T., Rowland, C. M., Catanese, J. J., Leong, D. U., Sninsky, J. J., Layden, T. J., Wright, T. L., White, T. and Cheung, R. C. (2007), A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology, 46: 297–306. doi: 10.1002/hep.21695
Potential conflict of interest: Dr. Shiffman is a consultant and received grants from Celera Diagnostics. Dr. Bzowej advises, is on the speakers' bureau of, and received grants fron Idenix. He also advises for Intarcia. He received grants from Gilead, Roche, Schering-Plough, Bristol-Myers Squibb, Vertex, Merck, and Novartis. Dr. Rowland owns stock in Celera Diagnostics and Applied Biosystems. Dr. Catanese owns stock in Celera Diagnostics. Dr. Cheung is a consultant for Celera Diagnostics.
- Issue online: 27 JUL 2007
- Version of Record online: 26 APR 2007
- Manuscript Accepted: 15 FEB 2007
- Manuscript Received: DEC 2006
- NIH. Grant Number: DK56621
- Feld Foundation
Supplementary material for this article can be found on the H EPATOLOGY website ( http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html ).
|jws-hep.21695.pdf||209K||Supporting Information file jws-hep.21695.pdf|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.